Bioequivalence and Bioavailability Forum 00:26 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

A lovely general sentence in an FDA warning letter [GxP / QC / QA]

posted by ElMaestro - Denmark, 2018-07-10 18:28  - Posting: # 19027
Views: 563

Hi all,


"Your acceptance of the passing results based on an assumed laboratory error was insufficient to invalidate the original failing result and conclude the investigation."


This little sentence portrays a general issue in the industry at the moment. Failure is not an option.
How many failed dissolution tests have you seen repeated this way? How many failed stabilities? How many failed A/P runs? And so forth.

if (3) 4

x=c("Foo", "Bar")
b=data.frame(x)
typeof(b[,1]) ##aha, integer?
b[,1]+1 ##then let me add 1



Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,154 posts in 4,080 threads, 1,308 registered users;
online 11 (0 registered, 11 guests [including 6 identified bots]).

One can show the following: given any rule, however “fundamental”
or “necessary” for science, there are always circumstances
when it is advisable not only to ignore the rule,
but to adopt its opposite.    Paul Feyerabend

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed